Day: June 18, 2024

WARREN, N.J., June 18, 2024 (GLOBE NEWSWIRE) — Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in oncology, neurology, and virology, highlights the commentary of Mittul Mehta, Tevogen’s Chief Information Officer and Head of Tevogen.AI, at the Longwood Spring MIT Conference. Mehta emphasized the transformative potential of Tevogen Bio’s innovative T cell technology and the company’s groundbreaking approach to overcoming industry challenges. Key Points from Mehta’s Commentary Realizing the Full Potential of T Cell Therapies. Mehta emphasized that the full potential of T cell-based therapies remains untapped due to various limitations, including the imbalance between the cost of manufacturing...

BOISE, Idaho, June 18, 2024 (GLOBE NEWSWIRE) — PCS Edventures!, Inc. (“PCSV”), a leading provider of K-12 Science, Technology, Engineering and Mathematics (“STEM”) education programs, today announced preliminary results of operations for its fiscal year ended March 31, 2024. On a preliminary basis, revenue was $9.1 million compared to $7.0 million in revenue for the same period last year. Net income before tax benefit was $2.9 million compared to $1.8 million in net income for the same period last year. The Company ended its fiscal year with $1.3 million in cash. Mike Bledsoe, President, commented, “While these results are preliminary, we feel confident that they represent what our audited financial statements will show in our 10-K Annual Report for the fiscal year ending March 31, 2024. We anticipate filing our 10-K on or before...

                                          Mr Guillaume PaoliCo-founder and Co-CEO          Mr Nicolas ChartierCo-founder and Co-CEO          are pleased to invite you to Aramis Group 2024 Capital Markets Day Wednesday, November 27, 2024 Please mark this date in your calendar, more information will be provided soon Aramis GroupE-mail: investor@aramis.group BrunswickE-mail: aramisgroup@brunswickgroup.comAttachmentAramis Group – Save the date Capital Markets Day 2024

CARY, North Carolina, June 18, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest community, Millstone, is coming soon to Cary, North Carolina. This exclusive Toll Brothers neighborhood will include 62 single-family home sites in one of the most desirable locations in the Raleigh area. Site work is underway and the community is anticipated to open for sale in fall 2024. Located in the heart of Cary, Millstone will feature expansive home designs offering 4-5 bedrooms and up to 5.5 bathrooms, with two-story great rooms and generous outdoor living spaces. Homes will offer up to 5,000+ square feet of living space and options for flexible spaces, home offices, and first-floor guest suites. Toll Brothers homes in Millstone will be priced from $1.1 million.Home...

EDMONTON, Alberta, June 18, 2024 (GLOBE NEWSWIRE) — Regenx Tech Corp., (the “Corporation” or “Regenx“) (CSE: RGX) (OTCQB: RGXT) (FSE: YRS WKN: A2DSW3) announced that, further to its June 12, 2024 news release, the Corporation has completed the consolidation (the “Consolidation”) of its Common Shares on the basis of 2 pre-Consolidation Common Shares for 1 post-Consolidation ‎Common Share, subject to regulatory approval, including approval of the Canadian Securities Exchange (the “CSE”). As of today, the Common Shares of the ‎Corporation will trade on a post-Consolidation basis on the CSE. Regenx engages US-Based investor relations firm The Company is pleased to announce it has engaged the US-based corporate communications firm, RB Milestone Group LLC (“RBMG”), to provide investor relations services including...

New capacity comes as Verizon marks its tenth anniversary serving Alaska IRVINE, Calif., June 18, 2024 (GLOBE NEWSWIRE) — Verizon recently expanded its network across Alaska, adding additional spectrum at 89 cell sites across the state to increase network capacity by approximately 30 percent. This newly expanded capacity benefits residents, businesses, and visitors in Kenai, Soldotna, Anchor Point, Homer, Seward, Meadow Lake, Denali Park, Two Rivers, and Pleasant Valley. This additional spectrum allows Verizon to provide greater bandwidth and enable higher data speeds for its customers in Alaska. This expansion comes as Verizon celebrates 10 years of delivering the most reliable network experience in Alaska, serving 87 percent of the state’s population. “Verizon is committed to delivering the most reliable network experience and...

Vancouver, BC, June 18, 2024 (GLOBE NEWSWIRE) — RevoluGROUP Canada Inc. (TSX-V: REVO), (Frankfurt: IJA2), (Munich: A2PU92) (the “Company”) announces with deep regret that Bernard Lonis, the esteemed Chairman of the Board and Director, has officially stepped down from his roles with the Company, effective June 18, 2024 due to ongoing health concerns. Mr. Lonis initially stepped aside from his duties on May 1st, 2024, as he was admitted in hospital. Lonis said: “Although I am recovering correctly, I am going to listen to this ”wake up call” my body has sent me and change my professional rhythm in all the companies and organizations where I am involved. Including Revolugroup where I will only stay as a major shareholder” Bernard Lonis has been an integral part of RevoluGROUP Canada Inc.’s growth and success over...

MIAMI, June 18, 2024 (GLOBE NEWSWIRE) — SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1 diabetes (T1D), today announced that it will present a poster at the ADA 84th Scientific Sessions on June 21-24, 2024 in Orlando, Florida. The poster will be presented by SAB’s Senior Program Manager, Eric Sandhurst, Ph.D, and published online in the journal Diabetes®. The American Diabetes Association 84th Scientific Sessions IND-Enabling Assessment of Tolerance and Safety for SAB-142—A First-in-Class Fully Human Anti-thymocyte Immunoglobulin to Delay the Progression of Type 1 Diabetes Date/Time: Sunday, Jun 23, 2024 12:30 PM – 1:30 PM.Location:...

LUXEMBOURG, June 18, 2024 (GLOBE NEWSWIRE) — Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) announced today that the Brazilian Superior Court of Justice (SCJ) resolved that Tenaris’s subsidiary Confab and certain subsidiaries of Tenaris’s affiliate Ternium, all of which compose the T/T Group under the Usiminas shareholders agreement, should pay Companhia Siderúrgica Nacional, or CSN, an indemnification in connection with the acquisition by the T/T Group of a participation in Usiminas in January 2012. CSN and various entities affiliated with CSN had filed a lawsuit in Brazil against the T/T Group, alleging that, under applicable Brazilian laws and rules, the acquirers were required to launch a tag-along tender offer to all non-controlling holders of Usiminas ordinary shares for a price per share equal to 80% of the price...